The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Romm Preston S since 2006.
The trader's CIK number is 1359475.
At the time of the last reporting, Romm Preston S was the VP of Finance & CFO of Obagi Medical Products, Inc.. (stock ticker symbol OMPI).
Also see all insider trading activities at Obagi Medical Products, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2006 | IOM | 17,850 | $41,996 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | OMPI | 0 | $0 | 95,471 | $1,258,285 | 95,471 | $918,186 |
| 2011 | OMPI | 0 | $0 | 33,334 | $326,978 | 33,334 | $195,335 |
2. Obagi Medical Products, Inc. (OMPI)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2006-08-01 | IOM | Buy | 14,000 | 2.35 | 32,872 |
| 2006-08-02 | IOM | Buy | 3,850 | 2.37 | 9,124 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-09-10 | OMPI | Option Ex | 17,644 | 7.93 | 139,916 |
| 2012-09-11 | OMPI | Option Ex | 77,827 | 10.00 | 778,270 |
| 2012-09-10 | OMPI | Sale | 17,644 | 13.27 | 234,082 |
| 2012-09-11 | OMPI | Sale | 77,827 | 13.16 | 1,024,203 |
| 2011-11-16 | OMPI | Option Ex | 9,586 | 5.86 | 56,173 |
| 2011-11-17 | OMPI | Option Ex | 10,569 | 5.86 | 61,934 |
| 2011-11-16 | OMPI | Sale | 9,586 | 9.95 | 95,332 |
| 2011-11-18 | OMPI | Option Ex | 13,179 | 5.86 | 77,228 |
| 2011-11-17 | OMPI | Sale | 10,569 | 9.80 | 103,586 |
| 2011-11-18 | OMPI | Sale | 13,179 | 9.72 | 128,060 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Romm Preston S (VP of Finance & CFO of Obagi Medical Products, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.